These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 20408897
1. Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction. Kim YC, Kim KK, Shevach EM. Immunology; 2010 Aug; 130(4):484-93. PubMed ID: 20408897 [Abstract] [Full Text] [Related]
2. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J, Monteleone G, Rose-John S, Neurath MF, Becker C. J Immunol; 2007 Aug 15; 179(4):2041-5. PubMed ID: 17675459 [Abstract] [Full Text] [Related]
3. Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells. Kagami S, Owada T, Kanari H, Saito Y, Suto A, Ikeda K, Hirose K, Watanabe N, Iwamoto I, Nakajima H. Int Immunol; 2009 Jun 15; 21(6):679-89. PubMed ID: 19380384 [Abstract] [Full Text] [Related]
4. Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance. Lee KJ, Moon JY, Choi HK, Kim HO, Hur GY, Jung KH, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Yoo SH, Kang KH, Lee SY. Clin Exp Immunol; 2010 Aug 15; 161(2):298-305. PubMed ID: 20491794 [Abstract] [Full Text] [Related]
11. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells. Lim DG, Park YH, Kim SE, Kim YH, Park CS, Kim SC, Park CG, Han DJ. Int Immunol; 2011 Sep 15; 23(9):583-92. PubMed ID: 21750147 [Abstract] [Full Text] [Related]
13. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W. Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651 [Abstract] [Full Text] [Related]
14. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells. Lei J, Hasegawa H, Matsumoto T, Yasukawa M. J Immunol; 2010 Dec 15; 185(12):7186-98. PubMed ID: 21057085 [Abstract] [Full Text] [Related]
15. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. Selvaraj RK, Geiger TL. J Immunol; 2007 Jul 15; 179(2):11 p following 1390. PubMed ID: 17695668 [Abstract] [Full Text] [Related]
16. DNA methylation controls Foxp3 gene expression. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J. Eur J Immunol; 2008 Jun 15; 38(6):1654-63. PubMed ID: 18493985 [Abstract] [Full Text] [Related]
17. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. Klunker S, Chong MM, Mantel PY, Palomares O, Bassin C, Ziegler M, Rückert B, Meiler F, Akdis M, Littman DR, Akdis CA. J Exp Med; 2009 Nov 23; 206(12):2701-15. PubMed ID: 19917773 [Abstract] [Full Text] [Related]
18. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner. Zhou H, Chen L, You Y, Zou L, Zou P. Autoimmunity; 2010 Jun 23; 43(4):299-307. PubMed ID: 20166879 [Abstract] [Full Text] [Related]